Terminalia Bellirica
OTHER NAME(S): Baheda, Bahera, Bahira, Balera, Behada, Beleric Myrobalan, Belleric Myrobalan, Belliric Myrobalan, Bhibitaki, Bibhitak, Bibitaki, Bihara, Kalidruma, Karshaphala, Myrobolan Bellirique, Terminalia belerica, Terminalia bellerica, Vibhitaki, Terminalia bellirica, Myrobalanus bellirica
Overview
Terminalia bellirica is a tree. Its fruit is traditionally used in Ayurvedic medicine in combination with Terminalia chebula and Indian gooseberry.
The fruit of the Terminalia bellirica tree contains chemicals that might affect digestion and protect the liver. It might also affect the heart, but less than other Terminalia species.
People use Terminalia bellirica for constipation, cough, diabetes, diarrhea, high cholesterol, and many other conditions, but there is no good scientific evidence to support these uses.
Don't confuse Terminalia bellirica with other Terminalia species, including Terminalia chebula and Terminalia arjuna. These are not the same.
Uses
We currently have no information for Terminalia bellirica overview.
Side Effects
When taken by mouth: Terminalia bellirica is possibly safe when used for up to 24 weeks. It seems to be well-tolerated.
Precautions
When taken by mouth: Terminalia bellirica is possibly safe when used for up to 24 weeks. It seems to be well-tolerated.
Pregnancy: Terminalia bellirica is possibly unsafe when taken by mouth during pregnancy. Stay on the safe side and avoid use.
Breast-feeding: There isn't enough reliable information to know if Terminalia bellirica is safe to use when breast-feeding. Stay on the safe side and avoid use.
Surgery: Terminalia bellirica might interfere with blood sugar control during surgery. Stop taking Terminalia bellirica at least 2 weeks before a scheduled surgery.
Interactions
Moderate Interaction
Be cautious with this combination
- Medications for diabetes (Antidiabetes drugs) interacts with Terminalia belliricaTerminalia bellirica might lower blood sugar levels. Taking Terminalia bellirica along with diabetes medications might cause blood sugar to drop too low. Monitor your blood sugar closely.
Dosing
There isn't enough reliable information to know what an appropriate dose of Terminalia bellirica might be. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult a healthcare professional before using.
References
- The Review of Natural Products by Facts and Comparisons. St. Louis, MO: Wolters Kluwer Co., 1999.
- Chevallier A. Encyclopedia of Medicinal Plants. New York, NY: DK Publishing, 1996.
- Anand KK, Singh B, Saxena AK, et al. 3,4,5-Trihydroxy benzoic acid (gallic acid), the hepatoprotective principle in the fruits of Terminalia belerica-bioassay guided activity. Pharmacol Res 1997;36:315-21.
- Shaila HP, Udupa SL, Udupa AL. Hypolipidemic activity of three indigenous drugs in experimentally induced atherosclerosis. Int J Cardiol 1998;67:119-214.
- Thakur CP, Thakur B, Singh S, et al. The Ayurvedic medicines Haritaki, Amala and Bahira reduce cholesterol-induced atherosclerosis in rabbits. Int J Cardiol 1988;21:167-75.
- Sabu, M. C. and Kuttan, R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002;81(2):155-160.
- Donato F, Raffetti E, Toninelli G, Festa A, Scarcella C, Castellano M; TRIGU Project Working Group. Guggulu and Triphala for the Treatment of Hypercholesterolaemia: A Placebo-Controlled, Double-Blind, Randomised Trial. Complement Med Res 2021;28(3):216-225.
- Das A, Naveen J, Sreerama YN, Gnanesh Kumar BS, Baskaran V. Low-glycemic foods with wheat, barley and herbs (Terminalia chebula, Terminalia bellerica and Emblica officinalis) inhibit a-amylase, a-glucosidase and DPP-IV activity in high fat and low dose streptozotocin-induced diabetic rat. J Food Sci Technol 2022;59(6):2177-2188.
- Kwandee P, Somnuk S, Wanikorn B, Nakphaichit M, Tunsagool P. Efficacy of Triphala extracts on the changes of obese fecal microbiome and metabolome in the human gut model. J Tradit Complement Med 2023;13(2):207-217.
- Pingali U, Nutalapati C, Koilagundla N, Taduri G. A randomized, double-blind, positive-controlled, prospective, dose-response clinical study to evaluate the efficacy and tolerability of an aqueous extract of Terminalia bellerica in lowering uric acid and creatinine levels in chronic kidney disease subjects with hyperuricemia. BMC Complement Med Ther. 2020;20(1):281.